---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-116476"
form_type: "8-K"
ticker: "HUMA"
cik: "0001818382"
company_name: "Humacyte, Inc."
filed_at: "2025-11-26T23:59:59+00:00"
generated_at: "2026-05-16T16:33:55.794727+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Humacyte terminates $80M at-the-market offering agreement with Jefferies

## Summary
- Agreement allowed sale of up to $80M in common stock via Jefferies as agent.
- Termination notice delivered November 21, 2025; effective 10 days later.
- Company is not subject to any termination penalties.
- No new financing or replacement agreement announced.

## SEC filing metadata
- accession: 0001104659-25-116476
- form_type: 8-K
- ticker: HUMA
- cik: 0001818382
- company_name: Humacyte, Inc.
- filed_at: 2025-11-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818382/000110465925116476/0001104659-25-116476-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818382/000110465925116476/tm2532300d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-116476
- JSON: https://secwatch.observer/filing/0001104659-25-116476.json
- Plain text: https://secwatch.observer/filing/0001104659-25-116476.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.